Crosstalk between Exercise-Derived Endocannabinoidome and Kynurenines: Potential Target Therapies for Obesity and Depression Symptoms

Author:

Wences Chirino Tiffany1ORCID,Rangel López Edgar2ORCID,Luna Angulo Alexandra1,Carrillo Mora Paul3,Landa Solis Carlos4,Samudio Cruz María Alejandra3,Fuentes Bello Alim C.1,Paniagua Pérez Rogelio5,Ríos Martínez Juan6,Sánchez Chapul Laura1ORCID

Affiliation:

1. Neuromuscular Diseases Laboratory, Clinical Neurosciences Division, National Institute of Rehabilitation “Luis Guillermo Ibarra Ibarra”, Mexico City 14389, Mexico

2. Cell Reprogramming Laboratory, National Institute of Neurology and Neurosurgery “Manuel Velasco Suárez”, Mexico City 14269, Mexico

3. Clinical Neurosciences Division, National Institute of Rehabilitation “Luis Guillermo Ibarra Ibarra”, Mexico City 14389, Mexico

4. Tissue Engineering, Cell Therapy, and Regenerative Medicine Unit, National Institute of Rehabilitation “Luis Guillermo Ibarra Ibarra”, Mexico City 14389, Mexico

5. Biochemistry Laboratory, National Institute of Rehabilitation “Luis Guillermo Ibarra Ibarra”, Mexico City 14389, Mexico

6. Health Sciences Research Institute, Mexican Navy, Mexico City 04470, Mexico

Abstract

The kynurenine pathway (KP) and the endocannabinoid system (ECS) are known to be deregulated in depression and obesity; however, it has been recognized that acute physical exercise has an important modulating role inducing changes in the mobilization of their respective metabolites—endocannabinoids (eCBs) and kynurenines (KYNs)—which overlap at some points, acting as important antidepressant, anti-nociceptive, anti-inflammatory, and antioxidant biomarkers. Therefore, the aim of this review is to analyze and discuss some recently performed studies to investigate the potential interactions between both systems, particularly those related to exercise-derived endocannabinoidome and kynurenine mechanisms, and to elucidate how prescription of physical exercise could represent a new approach for the clinical management of these two conditions.

Funder

National Rehabilitation Institute

Publisher

MDPI AG

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Reference113 articles.

1. (2021, June 09). Obesity and Overweight; Health Report. Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

2. (2023, March 31). Depressive Disorder; Health Report. Available online: https://www.who.int/news-room/fact-sheets/detail/depression.

3. Depression and obesity: Evidence of shared biological mechanisms;Milaneschi;Mol. Psychiatry,2019

4. Inflammation-related disorders in the tryptophan catabolite pathway in depression and somatization;Anderson;Adv. Protein Chem. Struct. Biol.,2012

5. Endocannabinoid system: Role in depression, reward and pain control (Review);Huang;Mol. Med. Rep.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3